Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 13.4B | 12.3B | 13.5B | 12.7B |
Cost of revenue | 6.1B | 5.4B | 5.9B | 5.6B |
Gross profit | 7.3B | 7.0B | 7.7B | 7.1B |
Operating expense | ||||
Research & development | 989.4M | 995.5M | 914.0M | 912.8M |
Selling general and admin | 4.6B | 4.6B | 4.4B | 4.4B |
Other operating expenses | — | — | — | — |
Operating income | 1.7B | 1.3B | 2.3B | 1.8B |
Non operating interest income | ||||
Income | 155.0M | 187.2M | 182.5M | 422.8M |
Expense | 426.0M | 426.5M | 423.1M | 452.9M |
Other income expense | -108.2M | -129.4M | -316.1M | 107.4M |
Pretax income | 1.3B | 972.9M | 1.8B | 1.9B |
Tax provision | 249.4M | 199.0M | 114.7M | 129.5M |
Net income | 1.0B | 784.5M | 1.8B | 1.8B |
Basic EPS | 0.5 | 0.4 | 0.8 | 0.8 |
Diluted EPS | 0.5 | 0.4 | 0.8 | 0.8 |
Basic average shares | 2.2B | 2.2B | 2.2B | 2.3B |
Diluted average shares | 2.2B | 2.2B | 2.3B | 2.3B |
EBITDA | 3.7B | 3.2B | 4.3B | 4.2B |
Net income from continuing op. | 1.0B | 774.0M | 1.6B | 1.7B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |